This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Therapeutic Drug Monitoring Markets

Table 3.30: Justification for Therapeutic Drug Monitoring of Antifungals 48

Table 3.31: Recommendation for Therapeutic Drug Monitoring of Antifungals 48

Table 4.1: Global Market Revenue Forecast for Therapeutic Drug Testing,

2009-2019 49

Table 4.2: U.S. Market Revenue Forecast for Therapeutic Drug Testing, 2009-2019

50

Table 4.3: Europe Market Revenue Forecast for Therapeutic Drug Testing,

2009-2019 51

Table 4.4: Japan Market Revenue Forecast for Therapeutic Drug Testing, 2009-2019

51

Table 4.5: Asia Excluding Japan Market Revenue Forecast – Therapeutic Drug

Testing, 2009-2019 51

Table 4.6: Central and Latin America Market Revenue Forecast – Therapeutic Drug

Testing, 2009-2019 52

Table 4.7: Middle East/Africa Market Revenue Forecast – Therapeutic Drug

Testing, 2009-2019 52

Table 4.8: Global Market Share Analysis for Therapeutic Drug Testing, 2012 53

Table 4.9: U.S. Market Share Analysis for Therapeutic Drug Testing, 2012 54

Table 4.10: Therapeutic Drug Monitoring Market Growth Drivers 55

Table 4.11: Therapeutic Drug Monitoring Market Entry Barriers and Risks 55

Table 4.12: Pitfalls of Therapeutic Drug Monitoring in Developing Countries 56

Table 5.1: Therapeutic Drug Monitoring Panel Available for Abbott Diagnostic

ARCHITECT Range

of Analyzers 58

Table 5.2: OraSure Portfolio of Drug Detection Methodologies 65

Table 5.3: Alpha Scientific Designs Drug of Abuse Testing Cut-Off Level 66

Table 5.4: Regulatory Clearance of Alpha Scientific Products for Drug Testing 67

Table 5.5: Available 510K Cleared Analytes for the Vision™ Integrated Drug Test

Cup 68

Table 6.1: Specifications of Abaxis Picolo Express 77

Table 6.2: Panel of Metabolites Detected by the Abaxis Picolo Express 77

Table 6.3: Panel of Assays Available for Abbott AxSYM System 78

Table 6.4: Panel of Assays Available for the Abbott ARCHITECH c4000 79

Table 6.5: Panel of Assays Available for the Abbott ARCHITECH i2000SR 80

Table 6.6: Specifications of Alfa Wassermann ACE Alera 82

Table 6.7: Test Panel for Alfa Wassermann ACE Alera 82

5 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 +1.21 0.06%
NASDAQ 4,828.3250 +15.6170 0.32%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs